Next Article in Journal
Targeting Leukemia Stem Cells in the Bone Marrow Niche
Next Article in Special Issue
Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin
Previous Article in Journal
Immune Landscape of Breast Cancers
Previous Article in Special Issue
In Vitro and In Vivo Biological Activities of Cissus adnata (Roxb.)
Article Menu
Issue 1 (March) cover image

Export Article

Open AccessCommunication
Biomedicines 2018, 6(1), 21; https://doi.org/10.3390/biomedicines6010021

Bryonolic Acid Blocks Cancer Cell Clonogenicity and Invasiveness through the Inhibition of Fatty Acid: Cholesteryl Ester Formation

1
Division of Preventive Oncology, National Center for Tumor Diseases, Im Neuenheimer Feld 460 and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, Heidelberg 69120, Germany
2
Team of Endocrinology and Nutrition Physiology, Faculté des Sciences et Techniques d’Errachidia (FSTE), Université Moulay Ismail, 509, Boutalamine, Errachidia 52000, Morocco
3
Cancer Research Center of Toulouse, Unité Mixte de Recherche (UMR) 1037 Institut National de la Santé et de la Recherche Médicale (INSERM)-University of Toulouse III, Toulouse F-31037, France
*
Authors to whom correspondence should be addressed.
Received: 15 January 2018 / Revised: 28 January 2018 / Accepted: 9 February 2018 / Published: 12 February 2018
(This article belongs to the Special Issue Plant Derived Biomedicines)
Full-Text   |   PDF [544 KB, uploaded 12 February 2018]   |  

Abstract

Bryonolic acid (BrA) is a pentacyclic triterpene present in several plants used in African traditional medicine such as Anisophyllea dichostyla R. Br. Here we investigated the in vitro anticancer properties of BrA. We report that BrA inhibits acyl-coA: cholesterol acyl transferase (ACAT) activity in rat liver microsomes in a concentration-dependent manner, blocking the biosynthesis of the cholesterol fatty acid ester tumour promoter. We next demonstrated that BrA inhibits ACAT in intact cancer cells with an IC50 of 12.6 ± 2.4 µM. BrA inhibited both clonogenicity and invasiveness of several cancer cell lines, establishing that BrA displays specific anticancer properties. BrA appears to be more potent than the other pentacyclic triterpenes, betulinic acid and ursolic acid studied under similar conditions. The inhibitory effect of BrA was reversed by exogenous addition of cholesteryl oleate, showing that ACAT inhibition is responsible for the anticancer effect of BrA. This report reveals new anticancer properties for BrA. View Full-Text
Keywords: cholesterol; metabolism; cholesteryl esters; tumour promoter; ChEH; cancer cell; invasiveness; colony formation cholesterol; metabolism; cholesteryl esters; tumour promoter; ChEH; cancer cell; invasiveness; colony formation
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Khallouki, F.; Owen, R.W.; Silvente-Poirot, S.; Poirot, M. Bryonolic Acid Blocks Cancer Cell Clonogenicity and Invasiveness through the Inhibition of Fatty Acid: Cholesteryl Ester Formation. Biomedicines 2018, 6, 21.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top